This is the authors' abstract. We don't add key points for this paper.
Chloronicotinic acids (CAs) are high‐value fine chemical intermediates for pharmaceuticals and agrochemicals. Chemical hydrolysis of mixed chloronicotinonitriles (CNs) derived from industrial raw materials suffers from poor substrate selectivity, complicated downstream processing, and low yield. To address these challenges, a sequential biosynthesis route was established for 6‐CA and 2‐CA. The nitrilase from Paraburkholderia graminis ( Pg NIT) exhibited strict selectivity and high activity toward 6‐CN, while a mutant Pg NIT‐9M with enhanced catalytic efficiency for 2‐CN was obtained via computer‐assisted design. The two enzymes were applied for stepwise bioproduction of 6‐CA and 2‐CA from a 2‐CN/6‐CN mixture. As a result, complete utilization of the mixed CN substrates was achieved, with the reaction yields of both 6‐CA and 2‐CA exceeding 99%. High‐purity 6‐CA and 2‐CA were obtained after further purification. This strategy realized green and efficient conversion of industrial mixed CNs, reduced resource waste and environmental pollution, and provided a sustainable biocatalytic route for CA production.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: